Moira successfully defended her thesis entitled “Fragment-to-Lead Optimization with Automated and Iterative Virtual Screening”. Her Fragment Evolution Automated platform (FrEvolAtion) has shown to be a powerful tool for Fragment-based Drug Discovery and her results finding binders for the NUDT1, BRD4, HSP90 and other kinases thoroughly validate the reach of the methodology.
We hope you have a great success in your future endeavours,
Congratulations Dra. Rachmann!